NCT03770936View on ClinicalTrials.gov

Effect of Some Drugs on Liver Fibrosis

PHASE3RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 31, 2026

Study Completion Date

November 30, 2027

Conditions
Liver Fibroses
Interventions
DRUG

Candesartan

Candesartan 8 mg/day

DRUG

Ramipril

ramipril 1.25 mg/day

Trial Locations (1)

35111

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Sherief Abd-Elsalam

OTHER

NCT03770936 - Effect of Some Drugs on Liver Fibrosis | Biotech Hunter | Biotech Hunter